These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36336684)

  • 21. Visceral Adipose Tissue and Non-alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes.
    Nobarani S; Alaei-Shahmiri F; Aghili R; Malek M; Poustchi H; Lahouti M; Khamseh ME
    Dig Dis Sci; 2022 Apr; 67(4):1389-1398. PubMed ID: 33788095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ectodysplasin A Is Increased in Non-Alcoholic Fatty Liver Disease, But Is Not Associated With Type 2 Diabetes.
    Bayliss J; Ooi GJ; De Nardo W; Shah YJH; Montgomery MK; McLean C; Kemp W; Roberts SK; Brown WA; Burton PR; Watt MJ
    Front Endocrinol (Lausanne); 2021; 12():642432. PubMed ID: 33746906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between glucose metabolism and non-alcoholic fatty liver disease severity in morbidly obese women.
    Bedogni G; Gastaldelli A; Tiribelli C; Agosti F; De Col A; Fessehatsion R; Sartorio A
    J Endocrinol Invest; 2014 Aug; 37(8):739-744. PubMed ID: 24906975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD.
    Permutt Z; Le TA; Peterson MR; Seki E; Brenner DA; Sirlin C; Loomba R
    Aliment Pharmacol Ther; 2012 Jul; 36(1):22-9. PubMed ID: 22554256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis.
    Kim JY; Park KJ; Hwang JY; Kim GH; Lee D; Lee YJ; Song EH; Yoo MG; Kim BJ; Suh YH; Roh GS; Gao B; Kim W; Kim WH
    J Hepatol; 2017 Aug; 67(2):349-359. PubMed ID: 28365312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Relationship between Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Measured by Controlled Attenuation Parameter.
    Chon YE; Kim KJ; Jung KS; Kim SU; Park JY; Kim do Y; Ahn SH; Chon CY; Chung JB; Park KH; Bae JC; Han KH
    Yonsei Med J; 2016 Jul; 57(4):885-92. PubMed ID: 27189281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes.
    Lomonaco R; Bril F; Portillo-Sanchez P; Ortiz-Lopez C; Orsak B; Biernacki D; Lo M; Suman A; Weber MH; Cusi K
    Diabetes Care; 2016 Apr; 39(4):632-8. PubMed ID: 26861926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of type 2 diabetes mellitus on liver histology among morbidly obese individuals. A cross-sectional study.
    Cazzo E; Jimenez LS; Gallo Fde F; Pareja JC; Chaim EA
    Sao Paulo Med J; 2016; 134(1):79-83. PubMed ID: 26786607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults.
    Guo W; Lu J; Qin P; Li X; Zhu W; Wu J; Xu N; Zhang Q
    Lipids Health Dis; 2020 Oct; 19(1):218. PubMed ID: 33028338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in Insulin Sensitivity, Secretion, and the Metabolic Clearance Rate of Glucose in Newly Diagnosed Type 2 Diabetes Mellitus Patients: The Influences of Body Mass Index and Fatty Liver.
    Xie Y; Li S; Chen R; He R; Qian L; Zou J; Luo Y; Zhang Y; Ji M; Liu Y
    Metab Syndr Relat Disord; 2022 Oct; 20(8):451-458. PubMed ID: 36260098
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevalence and Specific Manifestations of Non-alcoholic Fatty Liver Disease (NAFLD) and Diabetes Mellitus Type 2 Association in a Moroccan Population: A Cross-sectional Study.
    Assarrar I; Messaoudi N; Ongoth FEM; Abdellaoui W; Malki A; Rouf S; Abda N; Ismaili Z; Latrech H
    Rev Diabet Stud; 2022 Sep; 18(3):140-145. PubMed ID: 36309775
    [No Abstract]   [Full Text] [Related]  

  • 32. Association of serum retinoic acid with hepatic steatosis and liver injury in nonalcoholic fatty liver disease.
    Liu Y; Chen H; Wang J; Zhou W; Sun R; Xia M
    Am J Clin Nutr; 2015 Jul; 102(1):130-7. PubMed ID: 25948673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease.
    Patel NS; Peterson MR; Brenner DA; Heba E; Sirlin C; Loomba R
    Aliment Pharmacol Ther; 2013 Mar; 37(6):630-9. PubMed ID: 23383649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children.
    Bedogni G; Gastaldelli A; Manco M; De Col A; Agosti F; Tiribelli C; Sartorio A
    Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):120-6. PubMed ID: 20880682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the effects of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease.
    Shimizu M; Suzuki K; Kato K; Jojima T; Iijima T; Murohisa T; Iijima M; Takekawa H; Usui I; Hiraishi H; Aso Y
    Diabetes Obes Metab; 2019 Feb; 21(2):285-292. PubMed ID: 30178600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interest of hepatic steatosis index (HSI) in screening for metabolic steatopathy in patients with type 2 diabetes.
    Fennoun H; Mansouri SE; Tahiri M; Haraj NE; Aziz SE; Hadad F; Hliwa W; Badr W; Chadli A
    Pan Afr Med J; 2020; 37():270. PubMed ID: 33598084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of the ELF Test for Detecting Steatohepatitis in Morbid Obese Patients with Suspicion of Nonalcoholic Fatty Liver Disease.
    López IC; Aroca FG; Bernal MDF; Mompeán JAL; Bernal ÁB; Martínez AMH; Barba EM; Velasco JAN; Paricio PP
    Obes Surg; 2017 Sep; 27(9):2347-2353. PubMed ID: 28229316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin resistance predicts steatosis and fibrosis in morbidly obese patients undergoing bariatric surgery.
    Aller R; de Luis D; Pacheco D; Velasco MC; Izaola O; Sagrado MG
    J Investig Med; 2012 Oct; 60(7):1005-8. PubMed ID: 22847342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between non-alcoholic fatty liver and skeletal muscle mass to visceral fat area ratio in women with type 2 diabetes.
    Su X; Xu J; Zheng C
    BMC Endocr Disord; 2019 Jul; 19(1):76. PubMed ID: 31315613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
    Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X
    Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.